FDA Approved: POMBILITI ATGA — Original Application (AMICUS THERAPEUTICS US, LLC)

View source ↗

Summary

FDA approves POMBILITI ATGA (cipaglucosidase alfa-ATGA) as an original biologics license application for Pompe disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pompe Disease

Drugs mentioned

• POMBILITI ATGA (CIPAGLUCOSIDASE ALFA-ATGA)

Snippet

ORIG AP for POMBILITI ATGA (CIPAGLUCOSIDASE ALFA-ATGA)